SURF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Surface Oncology Insider Trading History Chart

Surface Oncology Share Price & Price History

^$1.07

+0.30 (1.20%)

As of 09/8/2023 01:00 AM ET

Surface Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2023	Chandra Adams	Insider	Sell	3,901	$0.94	$3,666.94	30,899
8/1/2023	Jessica Fees	CFO	Sell	9,434	$0.94	$8,867.96	101,915
8/1/2023	Robert W Ross	CEO	Sell	16,713	$0.94	$15,710.22	83,193

SEC Filings (Institutional Ownership Changes) for Surface Oncology (NASDAQ:SURF)

37.21% of Surface Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Surface Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2023	Black Maple Capital Management LP	266,736	$0.23M	0.1%	N/A	0.439%
8/7/2023	Acadian Asset Management LLC	868,620	$0.75M	0.0%	-17.4%	1.428%
7/10/2023	ARK Investment Management LLC	1,412,077	$1.23M	0.0%	-74.3%	2.326%
5/15/2023	EcoR1 Capital LLC	3,082,959	$2.15M	0.1%	-21.4%	5.078%
5/11/2023	Acadian Asset Management LLC	1,051,718	$0.73M	0.0%	-3.7%	1.732%
5/3/2023	Nikko Asset Management Americas Inc.	999,026	$0.65M	0.0%	-6.8%	1.645%
5/1/2023	Arete Wealth Advisors LLC	53,965	$37.71B	0.0%	N/A	0.089%
4/27/2023	Sumitomo Mitsui Trust Holdings Inc.	999,026	$0.70M	0.0%	-6.8%	1.645%
4/17/2023	ARK Investment Management LLC	5,496,146	$3.84M	0.0%	-1.3%	9.052%
2/15/2023	Tang Capital Management LLC	429,647	$0.35M	0.1%	N/A	0.710%
2/14/2023	Susquehanna International Group LLP	49,815	$41K	0.0%	+108.3%	0.082%
2/13/2023	Nikko Asset Management Americas Inc.	1,072,013	$0.86M	0.0%	-2.9%	1.771%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	1,072,013	$0.88M	0.0%	-2.9%	1.771%
1/30/2023	International Assets Investment Management LLC	48,830	$40K	0.0%	+28.7%	0.081%
1/25/2023	Eagle Rock Investment Company LLC	42,000	$41K	0.0%	+90.9%	0.069%
1/24/2023	International Assets Investment Management LLC	76,830	$50K	0.0%	+102.5%	0.127%
1/24/2023	ARK Investment Management LLC	5,567,224	$4.57M	0.0%	-7.8%	9.196%
11/15/2022	EcoR1 Capital LLC	3,924,713	$4.08M	0.1%	-15.7%	6.483%
11/14/2022	Forefront Analytics LLC	66,838	$70K	0.0%	+60.3%	0.110%
11/10/2022	Kingsbury Capital Investment Advisors LLC	144,217	$0.15M	0.2%	+69.3%	0.238%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	98,062	$0.10M	0.0%	N/A	0.162%
11/3/2022	Barclays PLC	417,765	$0.43M	0.0%	-3.0%	0.720%
10/21/2022	Sumitomo Mitsui Trust Holdings Inc.	1,104,230	$1.15M	0.0%	N/A	1.903%
10/17/2022	ARK Investment Management LLC	6,035,691	$6.28M	0.0%	+8.6%	10.400%
8/16/2022	DAFNA Capital Management LLC	1,100,000	$1.80M	0.5%	+61.8%	1.896%
8/15/2022	Laurion Capital Management LP	665,400	$1.09M	0.0%	N/A	1.147%
8/10/2022	Forefront Analytics LLC	41,688	$71K	0.0%	+111.5%	0.072%
8/9/2022	Kingsbury Capital Investment Advisors LLC	85,166	$0.14M	0.2%	+171.3%	0.147%
8/8/2022	Keybank National Association OH	26,455	$43K	0.0%	N/A	0.048%
8/5/2022	Los Angeles Capital Management LLC	32,663	$54K	0.0%	-83.7%	0.060%
7/11/2022	ARK Investment Management LLC	5,557,382	$10.28M	0.1%	+4.0%	10.176%
5/13/2022	Parkman Healthcare Partners LLC	209,148	$0.62M	0.2%	-19.2%	0.383%
5/11/2022	GSA Capital Partners LLP	27,568	$81K	0.0%	N/A	0.050%
5/9/2022	Forefront Analytics LLC	19,713	$62K	0.0%	N/A	0.036%
5/6/2022	Los Angeles Capital Management LLC	199,825	$0.59M	0.0%	+104.0%	0.366%
5/6/2022	Princeton Global Asset Management LLC	53,442	$0.16M	0.0%	N/A	0.098%
5/5/2022	Russell Investments Group Ltd.	9,240	$27K	0.0%	N/A	0.017%
5/4/2022	SummerHaven Investment Management LLC	134,167	$0.39M	0.2%	+4.8%	0.246%
5/4/2022	Formidable Asset Management LLC	11,150	$33K	0.0%	N/A	0.020%
4/29/2022	SG Americas Securities LLC	10,043	$30K	0.0%	-33.4%	0.021%
4/29/2022	C M Bidwell & Associates Ltd.	50,655	$0.15M	0.1%	+51.1%	0.108%
4/25/2022	Assenagon Asset Management S.A.	45,821	$0.14M	0.0%	N/A	0.098%
4/19/2022	ARK Investment Management LLC	5,343,116	$15.71M	0.1%	+0.3%	11.378%
4/12/2022	Connective Portfolio Management LLC	25,000	$71K	0.2%	-58.3%	0.053%
2/17/2022	Eagle Rock Investment Company LLC	22,000	$0.11M	0.0%	N/A	0.048%
2/14/2022	PDT Partners LLC	104,365	$0.50M	0.0%	N/A	0.226%
2/14/2022	DAFNA Capital Management LLC	315,000	$1.51M	0.4%	N/A	0.683%
2/10/2022	Qube Research & Technologies Ltd	25,371	$0.12M	0.0%	N/A	0.055%
2/10/2022	Acadian Asset Management LLC	163,214	$0.78M	0.0%	N/A	0.354%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	11,966	$57K	0.0%	-72.4%	0.026%
2/9/2022	Principal Financial Group Inc.	64,157	$0.31M	0.0%	-59.7%	0.139%
2/9/2022	Alps Advisors Inc.	53,388	$0.26M	0.0%	N/A	0.116%
2/9/2022	Dimensional Fund Advisors LP	404,977	$1.94M	0.0%	+52.4%	0.878%
2/8/2022	Raymond James & Associates	18,393	$88K	0.0%	-75.4%	0.040%
2/8/2022	Northern Trust Corp	311,139	$1.49M	0.0%	+6.3%	0.674%
2/7/2022	Victory Capital Management Inc.	328,228	$1.57M	0.0%	-4.3%	0.711%
2/7/2022	SG Americas Securities LLC	15,073	$72K	0.0%	-48.1%	0.033%
2/7/2022	Connective Portfolio Management LLC	60,000	$0.29M	0.5%	N/A	0.130%
2/7/2022	Arete Wealth Advisors LLC	55,807	$0.28M	0.0%	N/A	0.121%
2/3/2022	Advisor Group Holdings Inc.	12,366	$59K	0.0%	-28.9%	0.027%
2/2/2022	Oppenheimer & Co. Inc.	11,049	$53K	0.0%	-65.9%	0.024%
2/1/2022	Qube Research & Technologies Ltd	25,371	$0.12M	0.0%	N/A	0.055%
1/28/2022	Allspring Global Investments Holdings LLC	141,261	$0.68M	0.0%	N/A	0.306%
1/28/2022	ARK Investment Management LLC	5,326,127	$25.46M	0.1%	+15.3%	11.545%
1/24/2022	Strs Ohio	133,500	$0.64M	0.0%	+9.8%	0.289%
1/14/2022	Spire Wealth Management	11,000	$53K	0.0%	N/A	0.024%
11/16/2021	Schonfeld Strategic Advisors LLC	14,700	$0.11M	0.0%	N/A	0.032%
11/15/2021	Marshall Wace LLP	232,162	$1.76M	0.0%	N/A	0.503%
11/15/2021	HighVista Strategies LLC	13,932	$0.11M	0.1%	N/A	0.030%
11/15/2021	Dimensional Fund Advisors LP	265,667	$2.01M	0.0%	-57.6%	0.576%
11/12/2021	Parkman Healthcare Partners LLC	248,267	$1.88M	0.5%	+8.8%	0.538%
11/12/2021	The Manufacturers Life Insurance Company	21,704	$0.16M	0.0%	N/A	0.047%
11/12/2021	Oppenheimer & Co. Inc.	32,397	$0.25M	0.0%	-7.0%	0.070%
11/12/2021	Geode Capital Management LLC	609,257	$4.61M	0.0%	+23.6%	1.321%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	43,300	$0.33M	0.0%	N/A	0.094%
11/10/2021	NinePointTwo Capital LLC	16,206	$0.12M	0.0%	N/A	0.036%
11/10/2021	Goldman Sachs Group Inc.	1,199,889	$9.08M	0.0%	+56.4%	2.640%
11/10/2021	Citigroup Inc.	6,482	$49K	0.0%	-86.2%	0.014%
11/9/2021	Barclays PLC	24,838	$0.19M	0.0%	-58.3%	0.054%
11/9/2021	BlackRock Inc.	2,424,943	$18.36M	0.0%	-4.7%	5.257%
11/9/2021	Principal Financial Group Inc.	159,042	$1.20M	0.0%	-1.5%	0.345%
11/8/2021	Summit Global Investments	56,549	$0.43M	0.0%	N/A	0.124%
11/8/2021	Los Angeles Capital Management LLC	97,930	$0.74M	0.0%	N/A	0.215%
11/5/2021	Advisor Group Holdings Inc.	17,396	$0.13M	0.0%	+9.9%	0.038%
11/2/2021	Raymond James & Associates	74,898	$0.57M	0.0%	-29.5%	0.165%
11/2/2021	New York State Common Retirement Fund	14,753	$0.11M	0.0%	-48.2%	0.032%
11/2/2021	Victory Capital Management Inc.	343,108	$2.60M	0.0%	-0.9%	0.755%
11/1/2021	SG Americas Securities LLC	29,036	$0.22M	0.0%	N/A	0.064%
10/28/2021	International Assets Investment Management LLC	30,800	$0.23M	0.0%	+12.4%	0.068%
10/22/2021	Strs Ohio	121,600	$0.92M	0.0%	+12.6%	0.268%
8/16/2021	Morgan Stanley	733,295	$5.47M	0.0%	+252.6%	1.613%

Data available starting January 2016

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. As of September 8, 2023, Surface Oncology, Inc. operates as a subsidiary of Coherus BioSciences, Inc.

Today's Range

Now: $1.07

$1.07

50 Day Range

MA: $1.01

$0.88

$1.08

52 Week Range

Now: $1.07

$0.56

$1.43

Volume

N/A

Average Volume

430,375 shs

Market Capitalization

$65.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.75